Revised SPC: Dynastat (parecoxib sodium) – all formulations

SPC now warns that DRESS syndrome may occur with parecoxib exposure; patients appear to be at highest risk early in the course of therapy; often within the first month of treatment, and therefore should be monitored closely. History of DRESS syndrome is now a contraindication.


electronic Medicines compendium